<?xml version="1.0" encoding="utf-8"?>
<doi_batch xmlns="http://www.crossref.org/schema/5.3.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:fr="http://www.crossref.org/fundref.xsd" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" xmlns:ct="http://www.crossref.org/clinicaltrials.xsd" xmlns:rel="http://www.crossref.org/relations.xsd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" version="5.3.1" xsi:schemaLocation="http://www.crossref.org/schema/5.3.1 http://www.crossref.org/schemas/crossref5.3.1.xsd">
	<head>
		<doi_batch_id>elife-crossref-02935-20170717071707</doi_batch_id>
		<timestamp>20170717071707</timestamp>
		<depositor>
			<depositor_name>eLife</depositor_name>
			<email_address>production@elifesciences.org</email_address>
		</depositor>
		<registrant>eLife</registrant>
	</head>
	<body>
		<journal>
			<journal_metadata language="en">
				<full_title>eLife</full_title>
				<issn media_type="electronic">2050-084X</issn>
			</journal_metadata>
			<journal_issue>
				<publication_date media_type="online">
					<month>10</month>
					<day>01</day>
					<year>2014</year>
				</publication_date>
				<journal_volume>
					<volume>3</volume>
				</journal_volume>
			</journal_issue>
			<journal_article publication_type="full_text" reference_distribution_opts="any">
				<titles>
					<title>Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer</title>
				</titles>
				<contributors>
					<person_name contributor_role="author" sequence="first">
						<given_name>Young Seok</given_name>
						<surname>Ju</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Ludmil B</given_name>
						<surname>Alexandrov</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Moritz</given_name>
						<surname>Gerstung</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Inigo</given_name>
						<surname>Martincorena</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Serena</given_name>
						<surname>Nik-Zainal</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Manasa</given_name>
						<surname>Ramakrishna</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Helen R</given_name>
						<surname>Davies</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Elli</given_name>
						<surname>Papaemmanuil</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Gunes</given_name>
						<surname>Gundem</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Adam</given_name>
						<surname>Shlien</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Niccolo</given_name>
						<surname>Bolli</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Sam</given_name>
						<surname>Behjati</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Patrick S</given_name>
						<surname>Tarpey</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Jyoti</given_name>
						<surname>Nangalia</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>Cambridge University Hospitals NHS Foundation Trust</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>Department of Haematology, University of Cambridge</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Charles E</given_name>
						<surname>Massie</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>Cambridge University Hospitals NHS Foundation Trust</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>Department of Haematology, University of Cambridge</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Adam P</given_name>
						<surname>Butler</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Jon W</given_name>
						<surname>Teague</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>George S</given_name>
						<surname>Vassiliou</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>Cambridge University Hospitals NHS Foundation Trust</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>Department of Haematology, University of Cambridge</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Anthony R</given_name>
						<surname>Green</surname>
						<affiliations>
							<institution>
								<institution_name>Cambridge University Hospitals NHS Foundation Trust</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>Department of Haematology, University of Cambridge</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Ming-Qing</given_name>
						<surname>Du</surname>
						<affiliations>
							<institution>
								<institution_name>Cambridge University Hospitals NHS Foundation Trust</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Ashwin</given_name>
						<surname>Unnikrishnan</surname>
						<affiliations>
							<institution>
								<institution_name>Lowy Cancer Research Centre, University of New South Wales</institution_name>
								<institution_place>Sydney, Australia</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>John E</given_name>
						<surname>Pimanda</surname>
						<affiliations>
							<institution>
								<institution_name>Lowy Cancer Research Centre, University of New South Wales</institution_name>
								<institution_place>Sydney, Australia</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Bin Tean</given_name>
						<surname>Teh</surname>
						<affiliations>
							<institution>
								<institution_name>Laboratory of Cancer Epigenome, National Cancer Centre</institution_name>
								<institution_place>Singapore, Singapore</institution_place>
							</institution>
							<institution>
								<institution_name>Duke-NUS Graduate Medical School</institution_name>
								<institution_place>Singapore, Singapore</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Nikhil</given_name>
						<surname>Munshi</surname>
						<affiliations>
							<institution>
								<institution_name>Department of Hematologic Oncology, Dana-Farber Cancer Institute</institution_name>
								<institution_place>Boston, United States</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Mel</given_name>
						<surname>Greaves</surname>
						<affiliations>
							<institution>
								<institution_name>Institute of Cancer Research, Sutton</institution_name>
								<institution_place>London, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Paresh</given_name>
						<surname>Vyas</surname>
						<affiliations>
							<institution>
								<institution_name>Weatherall Institute for Molecular Medicine, University of Oxford</institution_name>
								<institution_place>Oxford, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Adel K</given_name>
						<surname>El-Naggar</surname>
						<affiliations>
							<institution>
								<institution_name>Department of Pathology, MD Anderson Cancer Center</institution_name>
								<institution_place>Houston, United States</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Tom</given_name>
						<surname>Santarius</surname>
						<affiliations>
							<institution>
								<institution_name>Cambridge University Hospitals NHS Foundation Trust</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>V Peter</given_name>
						<surname>Collins</surname>
						<affiliations>
							<institution>
								<institution_name>Cambridge University Hospitals NHS Foundation Trust</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Richard</given_name>
						<surname>Grundy</surname>
						<affiliations>
							<institution>
								<institution_name>Children's Brain Tumour Research Centre, University of Nottingham</institution_name>
								<institution_place>Nottingham, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Jack A</given_name>
						<surname>Taylor</surname>
						<affiliations>
							<institution>
								<institution_name>National Institute of Environmental Health Sciences, National Institute of Health</institution_name>
								<institution_place>Triangle, North Carolina, United States</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>D Neil</given_name>
						<surname>Hayes</surname>
						<affiliations>
							<institution>
								<institution_name>Department of Internal Medicine, University of North Carolina</institution_name>
								<institution_place>Chapel Hill, United States</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>David</given_name>
						<surname>Malkin</surname>
						<affiliations>
							<institution>
								<institution_name>Hospital for Sick Children, University of Toronto</institution_name>
								<institution_place>Toronto, Canada</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<organization contributor_role="author" sequence="additional">ICGC Breast Cancer Group</organization>
					<organization contributor_role="author" sequence="additional">ICGC Chronic Myeloid Disorders Group</organization>
					<organization contributor_role="author" sequence="additional">ICGC Prostate Cancer Group</organization>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Christopher S</given_name>
						<surname>Foster</surname>
						<affiliations>
							<institution>
								<institution_name>Department of Molecular and Clinical Cancer Medicine, University of Liverpool</institution_name>
								<institution_place>London, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>HCA Pathology Laboratories</institution_name>
								<institution_place>London, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Anne Y</given_name>
						<surname>Warren</surname>
						<affiliations>
							<institution>
								<institution_name>Cambridge University Hospitals NHS Foundation Trust</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Hayley C</given_name>
						<surname>Whitaker</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Research UK Cambridge Institute, University of Cambridge</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Daniel</given_name>
						<surname>Brewer</surname>
						<affiliations>
							<institution>
								<institution_name>Institute of Cancer Research, Sutton</institution_name>
								<institution_place>London, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>School of Biological Sciences, University of East Anglia</institution_name>
								<institution_place>Norwich, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Rosalind</given_name>
						<surname>Eeles</surname>
						<affiliations>
							<institution>
								<institution_name>Institute of Cancer Research, Sutton</institution_name>
								<institution_place>London, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Colin</given_name>
						<surname>Cooper</surname>
						<affiliations>
							<institution>
								<institution_name>Institute of Cancer Research, Sutton</institution_name>
								<institution_place>London, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>School of Biological Sciences, University of East Anglia</institution_name>
								<institution_place>Norwich, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>David</given_name>
						<surname>Neal</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Research UK Cambridge Institute, University of Cambridge</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Tapio</given_name>
						<surname>Visakorpi</surname>
						<affiliations>
							<institution>
								<institution_name>Institute of Biosciences and Medical Technology - BioMediTech and Fimlab Laboratories, University of Tampere and Tampere University Hospital</institution_name>
								<institution_place>Tampere, Finland</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>William B</given_name>
						<surname>Isaacs</surname>
						<affiliations>
							<institution>
								<institution_name>Department of Oncology, Johns Hopkins University</institution_name>
								<institution_place>Baltimore, United States</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>G Steven</given_name>
						<surname>Bova</surname>
						<affiliations>
							<institution>
								<institution_name>Institute of Biosciences and Medical Technology - BioMediTech and Fimlab Laboratories, University of Tampere and Tampere University Hospital</institution_name>
								<institution_place>Tampere, Finland</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Adrienne M</given_name>
						<surname>Flanagan</surname>
						<affiliations>
							<institution>
								<institution_name>Department of Histopathology, Royal National Orthopaedic Hospital</institution_name>
								<institution_place>Middlesex, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>University College London Cancer Institute, University College London</institution_name>
								<institution_place>London, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>P Andrew</given_name>
						<surname>Futreal</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>Department of Genomic Medicine, The University of Texas, MD Anderson Cancer Center, Houston</institution_name>
								<institution_place>Texas, United States</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Andy G</given_name>
						<surname>Lynch</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Research UK Cambridge Institute, University of Cambridge</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Patrick F</given_name>
						<surname>Chinnery</surname>
						<affiliations>
							<institution>
								<institution_name>Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University</institution_name>
								<institution_place>Newcastle-upon-tyne, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Ultan</given_name>
						<surname>McDermott</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>Cambridge University Hospitals NHS Foundation Trust</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Michael R</given_name>
						<surname>Stratton</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Peter J</given_name>
						<surname>Campbell</surname>
						<affiliations>
							<institution>
								<institution_name>Cancer Genome Project, Wellcome Trust Sanger Institute</institution_name>
								<institution_place>Hinxton, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>Cambridge University Hospitals NHS Foundation Trust</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
							<institution>
								<institution_name>Department of Haematology, University of Cambridge</institution_name>
								<institution_place>Cambridge, United Kingdom</institution_place>
							</institution>
						</affiliations>
					</person_name>
				</contributors>
				<jats:abstract>
					<jats:p>Recent sequencing studies have extensively explored the somatic alterations present in the nuclear genomes of cancers. Although mitochondria control energy metabolism and apoptosis, the origins and impact of cancer-associated mutations in mtDNA are unclear. In this study, we analyzed somatic alterations in mtDNA from 1675 tumors. We identified 1907 somatic substitutions, which exhibited dramatic replicative strand bias, predominantly C &gt; T and A &gt; G on the mitochondrial heavy strand. This strand-asymmetric signature differs from those found in nuclear cancer genomes but matches the inferred germline process shaping primate mtDNA sequence content. A number of mtDNA mutations showed considerable heterogeneity across tumor types. Missense mutations were selectively neutral and often gradually drifted towards homoplasmy over time. In contrast, mutations resulting in protein truncation undergo negative selection and were almost exclusively heteroplasmic. Our findings indicate that the endogenous mutational mechanism has far greater impact than any other external mutagens in mitochondria and is fundamentally linked to mtDNA replication.</jats:p>
				</jats:abstract>
				<jats:abstract abstract-type="executive-summary">
					<jats:p>The DNA in a cell's nucleus must be copied faithfully, and divided equally, when a cell divides to produce two new cells. Mistakes—or mutations—are sometimes made during the copying process, and mutations can also be introduced by exposing DNA to damaging agents known as mutagens, such as UV light or cigarette smoke. These mutations are then maintained in all of the descendants of the cell. Most of these mutations have no impact on the cell's characteristics (‘passenger mutations’). However, ‘driver mutations’ that allow cells to divide uncontrollably and spread to other body sites can lead to cancer.</jats:p>
					<jats:p>Mitochondria are cellular compartments that are responsible for generating the energy a cell needs to survive and are also responsible for initiating programmed cell death. Mitochondria contain their own DNA—entirely separate from that in the nucleus of the cell—that encodes the proteins most essential for energy production. Mitochondrial DNA molecules are frequently exposed to damaging molecules called reactive oxygen species that are produced by the mitochondria. Therefore, these reactive oxygen species have been thought to be one of the most important causes of mitochondrial DNA mutations. In addition, because cancer cells produce energy differently to normal cells, mutations in the mitochondrial DNA that change the ability of the mitochondria to produce energy have been conventionally thought to help normal cells to become cancerous. However, conclusive evidence for a link between cancer and mitochondrial DNA mutations is lacking.</jats:p>
					<jats:p>Ju et al. examined the mitochondrial DNA sequences taken from 1675 cancer biopsies from over thirty different types of cancer and compared these to normal tissue from the same patients. This revealed 1907 mutations in the mitochondrial DNA taken from the cancer cells. The pattern of the mutations suggests that the majority of the mutations are not introduced from reactive oxygen species, but from the errors the mitochondria themselves make in the process of duplicating their DNA when a cell divides. Unexpectedly, known mutagens, such as cigarette smoke or UV light, had a negligible effect on mitochondrial DNA mutations.</jats:p>
					<jats:p>Contrary to conventional wisdom, Ju et al. found no evidence that the mitochondrial DNA mutations help cancer to develop or spread. Instead, like passenger mutations found in the DNA in the cell nucleus, most mitochondrial genome mutations have no discernible effect. However, Ju et al. revealed that DNA mutations that damage normal mitochondrial activity are less likely to be maintained in cancer cells. Presumably, mitochondria containing these proteins produce less energy, and so a cell containing too many of these mutations will find it harder to survive. This shows that having enough correctly functioning mitochondria is essential for even cancer cells to thrive.</jats:p>
				</jats:abstract>
				<publication_date media_type="online">
					<month>10</month>
					<day>01</day>
					<year>2014</year>
				</publication_date>
				<acceptance_date>
					<month>09</month>
					<day>26</day>
					<year>2014</year>
				</acceptance_date>
				<publisher_item>
					<item_number item_number_type="article_number">e02935</item_number>
					<identifier id_type="doi">10.7554/eLife.02935</identifier>
				</publisher_item>
				<crossmark>
					<crossmark_policy>10.7554/eLife.02935</crossmark_policy>
					<crossmark_domains>
						<crossmark_domain>
							<domain>elifesciences.org</domain>
						</crossmark_domain>
					</crossmark_domains>
					<crossmark_domain_exclusive>false</crossmark_domain_exclusive>
					<custom_metadata>
						<assertion group_name="peer_review_taxonomy" label="Peer review transparency" name="peer_review_transparency">single anonymised</assertion>
						<assertion group_name="peer_review_taxonomy" label="Peer review interaction" name="peer_review_interaction">other reviewer(s), editor</assertion>
						<assertion group_name="peer_review_taxonomy" label="Peer review published" name="peer_review_published">review summaries, review reports, author/editor communication, reviewer identities reviewer opt in, editor identities</assertion>
						<assertion group_name="post_publication_commenting" label="Post publication commenting" name="post_publication_commenting">open (sign in with ORCID iD required)</assertion>
						<fr:program name="fundref">
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">
									Wellcome Trust
									<fr:assertion name="funder_identifier">http://dx.doi.org/10.13039/100004440</fr:assertion>
								</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">
									Wellcome Trust
									<fr:assertion name="funder_identifier">http://dx.doi.org/10.13039/100004440</fr:assertion>
								</fr:assertion>
								<fr:assertion name="award_number">Health Innovation Challenge Fund (HICF)</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">
									Kay Kendall Leukaemia Fund
									<fr:assertion name="funder_identifier">http://dx.doi.org/10.13039/501100000402</fr:assertion>
								</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">Chordoma Foundation</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">
									Adenoid Cystic Carcinoma Research Foundation
									<fr:assertion name="funder_identifier">http://dx.doi.org/10.13039/100006386</fr:assertion>
								</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">
									European Molecular Biology Organization
									<fr:assertion name="funder_identifier">http://dx.doi.org/10.13039/100004410</fr:assertion>
								</fr:assertion>
								<fr:assertion name="award_number">ALTF 1203_2012</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">
									National Institute for Health Research
									<fr:assertion name="funder_identifier">http://dx.doi.org/10.13039/501100000272</fr:assertion>
								</fr:assertion>
								<fr:assertion name="award_number">Biomedical Research Center at University College London Hospitals</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">
									Leukaemia and Lymphoma Research
									<fr:assertion name="funder_identifier">http://dx.doi.org/10.13039/501100000651</fr:assertion>
								</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">
									Cancer Research UK
									<fr:assertion name="funder_identifier">http://dx.doi.org/10.13039/501100000289</fr:assertion>
								</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">
									Leukemia and Lymphoma Society
									<fr:assertion name="funder_identifier">http://dx.doi.org/10.13039/100005189</fr:assertion>
								</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">European Union</fr:assertion>
								<fr:assertion name="award_number">Breast Cancer Somatic Genetics Study (BASIS)</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">National Cancer Research Institute</fr:assertion>
								<fr:assertion name="award_number">PROMPT: G0500966/75466</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">
									National Institute of Environmental Health Sciences
									<fr:assertion name="funder_identifier">http://dx.doi.org/10.13039/100000066</fr:assertion>
								</fr:assertion>
								<fr:assertion name="award_number">Intramural Research Program of the NIH</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">
									National Institute for Health Research
									<fr:assertion name="funder_identifier">http://dx.doi.org/10.13039/501100000272</fr:assertion>
								</fr:assertion>
								<fr:assertion name="award_number">Cambridge Biomedical Research Center</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">
									European Molecular Biology Organization
									<fr:assertion name="funder_identifier">http://dx.doi.org/10.13039/100004410</fr:assertion>
								</fr:assertion>
								<fr:assertion name="award_number">ALTF 1287-2012</fr:assertion>
							</fr:assertion>
							<fr:assertion name="fundgroup">
								<fr:assertion name="funder_name">
									Department of Health
									<fr:assertion name="funder_identifier">http://dx.doi.org/10.13039/501100000276</fr:assertion>
								</fr:assertion>
								<fr:assertion name="award_number">Health Innovation Challenge Fund (HICF)</fr:assertion>
							</fr:assertion>
						</fr:program>
						<ai:program name="AccessIndicators">
							<ai:license_ref applies_to="vor">http://creativecommons.org/publicdomain/zero/1.0/</ai:license_ref>
							<ai:license_ref applies_to="am">http://creativecommons.org/publicdomain/zero/1.0/</ai:license_ref>
							<ai:license_ref applies_to="tdm">http://creativecommons.org/publicdomain/zero/1.0/</ai:license_ref>
						</ai:program>
					</custom_metadata>
				</crossmark>
				<rel:program>
					<rel:related_item>
						<rel:description>Origins and functional consequences of somatic mitochondrial DNA mutations</rel:description>
						<rel:inter_work_relation identifier-type="accession" relationship-type="isSupplementedBy">EGAS00001000968</rel:inter_work_relation>
					</rel:related_item>
					<rel:related_item>
						<rel:description>TCGA DNA sequencing data</rel:description>
						<rel:inter_work_relation identifier-type="uri" relationship-type="references">http://cghub.ucsc.edu</rel:inter_work_relation>
					</rel:related_item>
				</rel:program>
				<archive_locations>
					<archive name="CLOCKSS"/>
				</archive_locations>
				<doi_data>
					<doi>10.7554/eLife.02935</doi>
					<resource>https://elifesciences.org/articles/02935</resource>
					<collection property="text-mining">
						<item>
							<resource mime_type="application/pdf">https://cdn.elifesciences.org/articles/02935/elife-02935-v2.pdf</resource>
						</item>
						<item>
							<resource mime_type="application/xml">https://cdn.elifesciences.org/articles/02935/elife-02935-v2.xml</resource>
						</item>
					</collection>
				</doi_data>
				<citation_list>
					<citation key="bib1">
						<journal_title>Nature</journal_title>
						<author>Alexandrov</author>
						<volume>500</volume>
						<first_page>415</first_page>
						<cYear>2013</cYear>
						<article_title>Signatures of mutational processes in human cancer</article_title>
						<doi>10.1038/nature12477</doi>
					</citation>
					<citation key="bib2">
						<journal_title>Nature Genetics</journal_title>
						<author>Andrews</author>
						<volume>23</volume>
						<first_page>147</first_page>
						<cYear>1999</cYear>
						<article_title>Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA</article_title>
						<doi>10.1038/13779</doi>
					</citation>
					<citation key="bib3">
						<journal_title>Human Molecular Genetics</journal_title>
						<author>Avital</author>
						<volume>21</volume>
						<first_page>4214</first_page>
						<cYear>2012</cYear>
						<article_title>Mitochondrial DNA heteroplasmy in diabetes and normal adults: role of acquired and inherited mutational patterns in twins</article_title>
						<doi>10.1093/hmg/dds245</doi>
					</citation>
					<citation key="bib4">
						<journal_title>Oncogene</journal_title>
						<author>Brandon</author>
						<volume>25</volume>
						<first_page>4647</first_page>
						<cYear>2006</cYear>
						<article_title>Mitochondrial mutations in cancer</article_title>
						<doi>10.1038/sj.onc.1209607</doi>
					</citation>
					<citation key="bib5">
						<journal_title>Annual Review of Genomics and Human Genetics</journal_title>
						<author>Calvo</author>
						<volume>11</volume>
						<first_page>25</first_page>
						<cYear>2010</cYear>
						<article_title>The mitochondrial proteome and human disease</article_title>
						<doi>10.1146/annurev-genom-082509-141720</doi>
					</citation>
					<citation key="bib6">
						<journal_title>Oncogene</journal_title>
						<author>Chatterjee</author>
						<volume>25</volume>
						<first_page>4663</first_page>
						<cYear>2006</cYear>
						<article_title>Mitochondrial DNA mutations in human cancer</article_title>
						<doi>10.1038/sj.onc.1209604</doi>
					</citation>
					<citation key="bib7">
						<journal_title>GeneReviews</journal_title>
						<author>Chinnery</author>
						<cYear>1993</cYear>
						<article_title>Mitochondrial Disorders Overview</article_title>
					</citation>
					<citation key="bib8">
						<journal_title>Cell</journal_title>
						<author>Clayton</author>
						<volume>28</volume>
						<first_page>693</first_page>
						<cYear>1982</cYear>
						<article_title>Replication of animal mitochondrial DNA</article_title>
						<doi>10.1016/0092-8674(82)90049-6</doi>
					</citation>
					<citation key="bib9">
						<journal_title>Nature Genetics</journal_title>
						<author>Coller</author>
						<volume>28</volume>
						<first_page>147</first_page>
						<cYear>2001</cYear>
						<article_title>High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection</article_title>
						<doi>10.1038/88859</doi>
					</citation>
					<citation key="bib10">
						<journal_title>Hepatology</journal_title>
						<author>De Alwis</author>
						<volume>50</volume>
						<first_page>992</first_page>
						<cYear>2009</cYear>
						<article_title>Human liver stem cells originate from the canals of Hering</article_title>
						<doi>10.1002/hep.23160</doi>
					</citation>
					<citation key="bib11">
						<journal_title>Free Radical Research</journal_title>
						<author>Delaney</author>
						<volume>46</volume>
						<first_page>420</first_page>
						<cYear>2012</cYear>
						<article_title>Chemical and biological consequences of oxidatively damaged guanine in DNA</article_title>
						<doi>10.3109/10715762.2011.653968</doi>
					</citation>
					<citation key="bib12">
						<journal_title>PLOS genetics</journal_title>
						<author>Ericson</author>
						<volume>8</volume>
						<first_page>e1002689</first_page>
						<cYear>2012</cYear>
						<article_title>Decreased mitochondrial DNA mutagenesis in human colorectal cancer</article_title>
						<doi>10.1371/journal.pgen.1002689</doi>
					</citation>
					<citation key="bib13">
						<journal_title>Genetics</journal_title>
						<author>Faith</author>
						<volume>165</volume>
						<first_page>735</first_page>
						<cYear>2003</cYear>
						<article_title>Likelihood analysis of asymmetrical mutation bias gradients in vertebrate mitochondrial genomes</article_title>
					</citation>
					<citation key="bib14">
						<journal_title>Discovery Medicine</journal_title>
						<author>Falk</author>
						<volume>14</volume>
						<first_page>389</first_page>
						<cYear>2012</cYear>
						<article_title>Mitochondrial disease genetic diagnostics: optimized whole-exome analysis for all MitoCarta nuclear genes and the mitochondrial genome</article_title>
					</citation>
					<citation key="bib15">
						<journal_title>Annual Review of Biochemistry</journal_title>
						<author>Falkenberg</author>
						<volume>76</volume>
						<first_page>679</first_page>
						<cYear>2007</cYear>
						<article_title>DNA replication and transcription in mammalian mitochondria</article_title>
						<doi>10.1146/annurev.biochem.76.060305.152028</doi>
					</citation>
					<citation key="bib16">
						<journal_title>Genome biology</journal_title>
						<author>Fisher</author>
						<volume>12</volume>
						<first_page>R1</first_page>
						<cYear>2011</cYear>
						<article_title>A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries</article_title>
						<doi>10.1186/gb-2011-12-1-r1</doi>
					</citation>
					<citation key="bib17">
						<journal_title>Nature Genetics</journal_title>
						<author>Freyer</author>
						<volume>44</volume>
						<first_page>1282</first_page>
						<cYear>2012</cYear>
						<article_title>Variation in germline mtDNA heteroplasmy is determined prenatally but modified during subsequent transmission</article_title>
						<doi>10.1038/ng.2427</doi>
					</citation>
					<citation key="bib18">
						<journal_title>Nature</journal_title>
						<author>1000 Genomes Project Consortium</author>
						<volume>467</volume>
						<first_page>1061</first_page>
						<cYear>2010</cYear>
						<article_title>A map of human genome variation from population-scale sequencing</article_title>
						<doi>10.1038/nature09534</doi>
					</citation>
					<citation key="bib19">
						<journal_title>Genome Biology</journal_title>
						<author>Goto</author>
						<volume>12</volume>
						<first_page>R59</first_page>
						<cYear>2011</cYear>
						<article_title>Dynamics of mitochondrial heteroplasmy in three families investigated via a repeatable re-sequencing study</article_title>
						<doi>10.1186/gb-2011-12-6-r59</doi>
					</citation>
					<citation key="bib20">
						<journal_title>Science</journal_title>
						<author>Gray</author>
						<volume>283</volume>
						<first_page>1476</first_page>
						<cYear>1999</cYear>
						<article_title>Mitochondrial evolution</article_title>
						<doi>10.1126/science.283.5407.1476</doi>
					</citation>
					<citation key="bib21">
						<journal_title>Nature</journal_title>
						<author>Greenman</author>
						<volume>446</volume>
						<first_page>153</first_page>
						<cYear>2007</cYear>
						<article_title>Patterns of somatic mutation in human cancer genomes</article_title>
						<doi>10.1038/nature05610</doi>
					</citation>
					<citation key="bib22">
						<journal_title>Genetics</journal_title>
						<author>Greenman</author>
						<volume>173</volume>
						<first_page>2187</first_page>
						<cYear>2006</cYear>
						<article_title>Statistical analysis of pathogenicity of somatic mutations in cancer</article_title>
						<doi>10.1534/genetics.105.044677</doi>
					</citation>
					<citation key="bib23">
						<journal_title>Cell</journal_title>
						<author>Hanahan</author>
						<volume>144</volume>
						<first_page>646</first_page>
						<cYear>2011</cYear>
						<article_title>Hallmarks of cancer: the next generation</article_title>
						<doi>10.1016/j.cell.2011.02.013</doi>
					</citation>
					<citation key="bib24">
						<journal_title>Nature</journal_title>
						<author>He</author>
						<volume>464</volume>
						<first_page>610</first_page>
						<cYear>2010</cYear>
						<article_title>Heteroplasmic mitochondrial DNA mutations in normal and tumour cells</article_title>
						<doi>10.1038/nature08802</doi>
					</citation>
					<citation key="bib25">
						<journal_title>Cold Spring Harbor perspectives in biology</journal_title>
						<author>Holt</author>
						<volume>4</volume>
						<first_page>a012971</first_page>
						<cYear>2012</cYear>
						<article_title>Human mitochondrial DNA replication</article_title>
						<doi>10.1101/cshperspect.a012971</doi>
					</citation>
					<citation key="bib26">
						<journal_title>Human molecular genetics</journal_title>
						<author>Hudson</author>
						<volume>15</volume>
						<first_page>R244</first_page>
						<cYear>2006</cYear>
						<article_title>Mitochondrial DNA polymerase-gamma and human disease</article_title>
						<doi>10.1093/hmg/ddl233</doi>
					</citation>
					<citation key="bib27">
						<journal_title>Nucleic Acids Research</journal_title>
						<author>Ingman</author>
						<volume>34</volume>
						<first_page>D749</first_page>
						<cYear>2006</cYear>
						<article_title>mtDB: human Mitochondrial Genome Database, a resource for population genetics and medical sciences</article_title>
						<doi>10.1093/nar/gkj010</doi>
					</citation>
					<citation key="bib28">
						<volume_title>The neutral theory of molecular evolution</volume_title>
						<author>Kimura</author>
						<cYear>1984</cYear>
					</citation>
					<citation key="bib29">
						<journal_title>Genome Research</journal_title>
						<author>Koboldt</author>
						<volume>22</volume>
						<first_page>568</first_page>
						<cYear>2012</cYear>
						<article_title>VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing</article_title>
						<doi>10.1101/gr.129684.111</doi>
					</citation>
					<citation key="bib30">
						<journal_title>Nature Reviews Cancer</journal_title>
						<author>Koppenol</author>
						<volume>11</volume>
						<first_page>325</first_page>
						<cYear>2011</cYear>
						<article_title>Otto Warburg's contributions to current concepts of cancer metabolism</article_title>
						<doi>10.1038/nrc3038</doi>
					</citation>
					<citation key="bib31">
						<journal_title>Proceedings of the National Academy of Sciences of USA</journal_title>
						<author>Larman</author>
						<volume>109</volume>
						<first_page>14087</first_page>
						<cYear>2012</cYear>
						<article_title>Spectrum of somatic mitochondrial mutations in five cancers</article_title>
						<doi>10.1073/pnas.1211502109</doi>
					</citation>
					<citation key="bib32">
						<journal_title>Journal of Cell Science</journal_title>
						<author>Legros</author>
						<volume>117</volume>
						<first_page>2653</first_page>
						<cYear>2004</cYear>
						<article_title>Organization and dynamics of human mitochondrial DNA</article_title>
						<doi>10.1242/jcs.01134</doi>
					</citation>
					<citation key="bib33">
						<journal_title>Genome Biology and Evolution</journal_title>
						<author>Levin</author>
						<volume>5</volume>
						<first_page>876</first_page>
						<cYear>2013</cYear>
						<article_title>Functional recurrent mutations in the human mitochondrial phylogeny: dual roles in evolution and disease</article_title>
						<doi>10.1093/gbe/evt058</doi>
					</citation>
					<citation key="bib34">
						<journal_title>Bioinformatics</journal_title>
						<author>Li</author>
						<volume>25</volume>
						<first_page>1754</first_page>
						<cYear>2009</cYear>
						<article_title>Fast and accurate short read alignment with Burrows-Wheeler transform</article_title>
						<doi>10.1093/bioinformatics/btp324</doi>
					</citation>
					<citation key="bib35">
						<journal_title>American Journal of Human Genetics</journal_title>
						<author>Li</author>
						<volume>87</volume>
						<first_page>237</first_page>
						<cYear>2010</cYear>
						<article_title>Detecting heteroplasmy from high-throughput sequencing of complete human mitochondrial DNA genomes</article_title>
						<doi>10.1016/j.ajhg.2010.07.014</doi>
					</citation>
					<citation key="bib36">
						<journal_title>Nature</journal_title>
						<author>Lindahl</author>
						<volume>362</volume>
						<first_page>709</first_page>
						<cYear>1993</cYear>
						<article_title>Instability and decay of the primary structure of DNA</article_title>
						<doi>10.1038/362709a0</doi>
					</citation>
					<citation key="bib37">
						<journal_title>Cell</journal_title>
						<author>Nik-Zainal</author>
						<volume>149</volume>
						<first_page>979</first_page>
						<cYear>2012a</cYear>
						<article_title>Mutational processes molding the genomes of 21 breast cancers</article_title>
						<doi>10.1016/j.cell.2012.04.024</doi>
					</citation>
					<citation key="bib38">
						<journal_title>Cell</journal_title>
						<author>Nik-Zainal</author>
						<volume>149</volume>
						<first_page>994</first_page>
						<cYear>2012b</cYear>
						<article_title>The life history of 21 breast cancers</article_title>
						<doi>10.1016/j.cell.2012.04.023</doi>
					</citation>
					<citation key="bib39">
						<journal_title>Gene</journal_title>
						<author>Nikolaou</author>
						<volume>381</volume>
						<first_page>34</first_page>
						<cYear>2006</cYear>
						<article_title>Deviations from Chargaff's second parity rule in organellar DNA Insights into the evolution of organellar genomes</article_title>
						<doi>10.1016/j.gene.2006.06.010</doi>
					</citation>
					<citation key="bib40">
						<journal_title>Current Biology</journal_title>
						<author>Pavlov</author>
						<volume>13</volume>
						<first_page>744</first_page>
						<cYear>2003</cYear>
						<article_title>Evidence for preferential mismatch repair of lagging strand DNA replication errors in yeast</article_title>
						<doi>10.1016/S0960-9822(03)00284-7</doi>
					</citation>
					<citation key="bib41">
						<journal_title>Molecular Cell</journal_title>
						<author>Pavlov</author>
						<volume>10</volume>
						<first_page>207</first_page>
						<cYear>2002</cYear>
						<article_title>Yeast origins establish a strand bias for replicational mutagenesis</article_title>
						<doi>10.1016/S1097-2765(02)00567-1</doi>
					</citation>
					<citation key="bib42">
						<journal_title>Human Molecular Genetics</journal_title>
						<author>Payne</author>
						<volume>22</volume>
						<first_page>384</first_page>
						<cYear>2013</cYear>
						<article_title>Universal heteroplasmy of human mitochondrial DNA</article_title>
						<doi>10.1093/hmg/dds435</doi>
					</citation>
					<citation key="bib43">
						<journal_title>Nature</journal_title>
						<author>Pleasance</author>
						<volume>463</volume>
						<first_page>191</first_page>
						<cYear>2010a</cYear>
						<article_title>A comprehensive catalogue of somatic mutations from a human cancer genome</article_title>
						<doi>10.1038/nature08658</doi>
					</citation>
					<citation key="bib44">
						<journal_title>Nature</journal_title>
						<author>Pleasance</author>
						<volume>463</volume>
						<first_page>184</first_page>
						<cYear>2010b</cYear>
						<article_title>A small-cell lung cancer genome with complex signatures of tobacco exposure</article_title>
						<doi>10.1038/nature08629</doi>
					</citation>
					<citation key="bib45">
						<journal_title>Nature Genetics</journal_title>
						<author>Polyak</author>
						<volume>20</volume>
						<first_page>291</first_page>
						<cYear>1998</cYear>
						<article_title>Somatic mutations of the mitochondrial genome in human colorectal tumours</article_title>
						<doi>10.1038/3108</doi>
					</citation>
					<citation key="bib46">
						<journal_title>Genetica</journal_title>
						<author>Rand</author>
						<volume>139</volume>
						<first_page>685</first_page>
						<cYear>2011</cYear>
						<article_title>Population genetics of the cytoplasm and the units of selection on mitochondrial DNA in Drosophila melanogaster</article_title>
						<doi>10.1007/s10709-011-9576-y</doi>
					</citation>
					<citation key="bib47">
						<journal_title>Nucleic Acids Research</journal_title>
						<author>Ruiz-Pesini</author>
						<volume>35</volume>
						<first_page>D823</first_page>
						<cYear>2007</cYear>
						<article_title>An enhanced MITOMAP with a global mtDNA mutational phylogeny</article_title>
						<doi>10.1093/nar/gkl927</doi>
					</citation>
					<citation key="bib48">
						<journal_title>Gene</journal_title>
						<author>Saccone</author>
						<volume>238</volume>
						<first_page>195</first_page>
						<cYear>1999</cYear>
						<article_title>Evolutionary genomics in Metazoa: the mitochondrial DNA as a model system</article_title>
						<doi>10.1016/S0378-1119(99)00270-X</doi>
					</citation>
					<citation key="bib49">
						<journal_title>Nature Reviews Genetics</journal_title>
						<author>Schon</author>
						<volume>13</volume>
						<first_page>878</first_page>
						<cYear>2012</cYear>
						<article_title>Human mitochondrial DNA: roles of inherited and somatic mutations</article_title>
						<doi>10.1038/nrg3275</doi>
					</citation>
					<citation key="bib50">
						<journal_title>Nature Reviews Genetics</journal_title>
						<author>Smeitink</author>
						<volume>2</volume>
						<first_page>342</first_page>
						<cYear>2001</cYear>
						<article_title>The genetics and pathology of oxidative phosphorylation</article_title>
						<doi>10.1038/35072063</doi>
					</citation>
					<citation key="bib51">
						<journal_title>Nature</journal_title>
						<author>Stratton</author>
						<volume>458</volume>
						<first_page>719</first_page>
						<cYear>2009</cYear>
						<article_title>The cancer genome</article_title>
						<doi>10.1038/nature07943</doi>
					</citation>
					<citation key="bib52">
						<journal_title>The Journal of Clinical Investigation</journal_title>
						<author>Taylor</author>
						<volume>112</volume>
						<first_page>1351</first_page>
						<cYear>2003</cYear>
						<article_title>Mitochondrial DNA mutations in human colonic crypt stem cells</article_title>
						<doi>10.1172/JCI19435</doi>
					</citation>
					<citation key="bib53">
						<journal_title>Nature Genetics</journal_title>
						<author>Thilly</author>
						<volume>34</volume>
						<first_page>255</first_page>
						<cYear>2003</cYear>
						<article_title>Have environmental mutagens caused oncomutations in people?</article_title>
						<doi>10.1038/ng1205</doi>
					</citation>
					<citation key="bib54">
						<journal_title>Brief Bioinform</journal_title>
						<author>Thorvaldsdottir</author>
						<volume>14</volume>
						<first_page>178</first_page>
						<cYear>2013</cYear>
						<article_title>Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration</article_title>
						<doi>10.1093/bib/bbs017</doi>
					</citation>
					<citation key="bib55">
						<journal_title>Nature Reviews Cancer</journal_title>
						<author>Wallace</author>
						<volume>12</volume>
						<first_page>685</first_page>
						<cYear>2012</cYear>
						<article_title>Mitochondria and cancer</article_title>
						<doi>10.1038/nrc3365</doi>
					</citation>
					<citation key="bib56">
						<journal_title>Genetics</journal_title>
						<author>Wright</author>
						<volume>16</volume>
						<first_page>97</first_page>
						<cYear>1931</cYear>
						<article_title>Evolution in Mendelian populations</article_title>
					</citation>
					<citation key="bib57">
						<journal_title>The EMBO Journal</journal_title>
						<author>Yasukawa</author>
						<volume>25</volume>
						<first_page>5358</first_page>
						<cYear>2006</cYear>
						<article_title>Replication of vertebrate mitochondrial DNA entails transient ribonucleotide incorporation throughout the lagging strand</article_title>
						<doi>10.1038/sj.emboj.7601392</doi>
					</citation>
					<citation key="bib58">
						<journal_title>Molecular Cell</journal_title>
						<author>Yasukawa</author>
						<volume>18</volume>
						<first_page>651</first_page>
						<cYear>2005</cYear>
						<article_title>A bidirectional origin of replication maps to the major noncoding region of human mitochondrial DNA</article_title>
						<doi>10.1016/j.molcel.2005.05.002</doi>
					</citation>
					<citation key="bib59">
						<journal_title>Mutation Research</journal_title>
						<author>Zheng</author>
						<volume>599</volume>
						<first_page>11</first_page>
						<cYear>2006</cYear>
						<article_title>Origins of human mitochondrial point mutations as DNA polymerase gamma-mediated errors</article_title>
						<doi>10.1016/j.mrfmmm.2005.12.012</doi>
					</citation>
				</citation_list>
				<component_list>
					<component parent_relation="isPartOf">
						<titles>
							<title>Abstract</title>
						</titles>
						<format mime_type="text/plain"/>
						<doi_data>
							<doi>10.7554/eLife.02935.001</doi>
							<resource>https://elifesciences.org/articles/02935#abstract</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>eLife digest</title>
						</titles>
						<format mime_type="text/plain"/>
						<doi_data>
							<doi>10.7554/eLife.02935.002</doi>
							<resource>https://elifesciences.org/articles/02935#digest</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Table 1.</title>
						</titles>
						<format mime_type="text/plain"/>
						<doi_data>
							<doi>10.7554/eLife.02935.003</doi>
							<resource>https://elifesciences.org/articles/02935#tbl1</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 1. Mitochondrial somatic substitutions identified from 1675 Tumor–Normal pairs.</title>
							<subtitle>mtDNA genes and intergenic regions are shown. The strand of genes is shown based on mtDNA strand containing equivalent sequences of transcribed RNA. Substitution categories (silent, non-silent (missense and nonsense), non-coding (tRNA and rRNA), and intergenic) are shown by the shapes of each substitution. Six classes of substitutions are presented color-coded. The substitutions on the H, and L strand (when six substitutional classes were considered) are shown outside and inside of mtDNA genes, respectively. Vertical axes for H and L strand substitutions represent the VAF of each variant.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.004</doi>
							<resource>https://elifesciences.org/articles/02935#fig1</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 1—figure supplement 1. Correlation in amount of mtDNA reads between whole-genome and whole-exome sequencing.</title>
							<subtitle>139 DNA samples, either from tumors or bloods, sequenced by whole-genome sequencing were additionally sequenced by whole-exome sequencing. We compared the amount of mtDNA reads between whole-genome and whole-exome sequencing. As shown in this figure, we found strong positive correlation. * CGP; Cancer Genome Project, Wellcome Trust Sanger Institute, WUGSC; Washington University Genome Sequencing Center.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.005</doi>
							<resource>https://elifesciences.org/articles/02935/figures#fig1s1</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 1—figure supplement 2. Correlation of heteroplasmy levels between whole-genome and whole-exome sequencing.</title>
							<subtitle>To validate the sensitivity and specificity of variant calling in this study, 19 tumor and normal pairs (which were originally whole-genome sequenced) were whole-exome sequenced and mtDNA variants were assessed independently. We correlated the heteroplasmic levels of 20 mutations detected in common.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.006</doi>
							<resource>https://elifesciences.org/articles/02935/figures#fig1s2</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 1—figure supplement 3. Validation of mtDNA somatic substitutions.</title>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.007</doi>
							<resource>https://elifesciences.org/articles/02935/figures#fig1s3</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 1—figure supplement 4. Amount of off-target mtDNA reads across four sequencing centers.</title>
							<subtitle>* CGP; Cancer Genome Project, Wellcome Trust Sanger Institute (n = 855), WUGSC; Washington University Genome Sequencing Center (n = 140), BCM; Baylor College of Medicine (n = 85), BI; Broad Institute (n = 435).</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.008</doi>
							<resource>https://elifesciences.org/articles/02935/figures#fig1s4</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 1—figure supplement 5. Filtering samples of potential DNA contaminations.</title>
							<subtitle>(A) A histogram presenting potential sample swaps in tumor–sample pairs. (B) A histogram presenting potential minor DNA cross-contamination in tumor samples. Cross-contamination levels were considered in filtering substitutions (see “Minor cross-contamination of DNA samples” section in Materials and Methods). (C) Histograms showing number of somatic substitutions overlapping with known inherited polymorphisms and (D) number of back mutations.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.009</doi>
							<resource>https://elifesciences.org/articles/02935/figures#fig1s5</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 2. mtDNA somatic substitutions of human cancer.</title>
							<subtitle>(A) Number of somatic substitutions in a tumor sample. (B) Average number of somatic substitutions per sample across 31 tumor types. (C) Age of diagnosis and number of mtDNA somatic substitutions in breast cancers.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.010</doi>
							<resource>https://elifesciences.org/articles/02935#fig2</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 2—figure supplement 1. VAFs of phased somatic mtDNA substitutions.</title>
							<subtitle>This figure presents VAF pairs between co-clonal, sub-clonal, and different strand mtDNA substitutions. We expect similar VAFs for co-clonal pairs; lower VAF in sub-clonal mutations compared to clonal ones; and sum of a VAF pair is equal or less than 1.0.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.011</doi>
							<resource>https://elifesciences.org/articles/02935/figures#fig2s1</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 3. Replicative strand bias for mtDNA somatic substitutions.</title>
							<subtitle>(A) Replicative strand-specific substitution rate (# of observed/# of expected) by 96 trinucleotide context. Substitutions in a specific mtDNA segment (from Ori-b to OH) are not included, because they present a different substitutional signature. (B) Mutational signature across tumor types. Eighteen tumor types, which include at least 25 mtDNA mutations, were shown. (C) Inverted substitution signature in the Ori-b–OH.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.012</doi>
							<resource>https://elifesciences.org/articles/02935#fig3</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 3—figure supplement 1. Replicative strand bias observed in mtDNA substitutions.</title>
							<subtitle>(A) Mutational signature of mtDNA somatic substitutions on the 12 L strand genes by replicative strand (L/H strand). It agrees very well with the background mutational signature. (Chi-square p = 0.99999). (B) Mutational signature of mtDNA somatic substitutions on the H strand gene (MT-ND6) by replicative strand. It is very close to the background very close to the expected background signature (Chi-square p = 0.027). If we consider signature by transcriptional strand, the signature difference is very clear (Chi-square p = 1 × 10−21). These suggest the strand bias not to be transcription-coupled, but replication coupled. (C) Mutational spectrum of mtDNA somatic substitutions on the 22 tRNA genes by replicative strand. Again, it agrees very well with the background mutational signature (Chi-square p = 0.71). (D) Mutational spectrum of mtDNA somatic substitutions on the 22 tRNA genes by non-transcribed (coding) and transcribed (non-coding) strand. Strand bias was greatly subsided because somatic substitutions on 14 L strand and 8 H strand tRNAs neutralize the strand bias (CH &gt; TH and TL &gt; CL) each other. As a result, this signature of tRNA mutations by transcriptional strand is significantly different from the background one (Chi-square p = 3.3 × 10−12). Taken all together, we concluded that the cause of strand bias is not transcription-coupled but is replicative.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.013</doi>
							<resource>https://elifesciences.org/articles/02935/figures#fig3s1</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 4. Mutational signature similar to processes shaping human mtDNA sequence over evolutionary time.</title>
							<subtitle>(A) Triplet codon depletion in human mtDNA by equivalent (CH &gt; TH and TL &gt; CL) mutational pressure. Relative frequency of each triplet codon within synonymous pairs (NNT–NNC or NNA–NNG) is shown by color. The arrows beside the box highlight the T &gt; C (red) and G &gt; A (blue) substitutional pressures on the L strand in germline mtDNA. (B) Correlation of triplet codon frequencies between from observed and from simulated evolutions of a random sequence mtDNA by the mtDNA somatic mutational signature with constraining mitochondrial protein sequences.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.014</doi>
							<resource>https://elifesciences.org/articles/02935#fig4</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 4—figure supplement 1. TC and GA skew for L strand mtDNA genes across 8 animal species.</title>
							<subtitle>C. elegans (a nematode) and D. melanogaster (fruit fly) mtDNA appears to have GL &lt;&lt; AL (due to CH &gt; TH mutational pressure) and CL &gt;&gt; TL (due to CL &gt; TL mutational pressure) in the third base of triplet codon in L strand genes. Therefore they seem to have predominant C &gt; T mutational pressure without strand bias. D. rerio (zebrafish), X. laevis (frog), and M. musculus (mouse) present GL &lt;&lt; AL (due to CH &gt; TH mutational pressure), but similar number of CL and TL. Therefore, mtDNA of these sequences is thought to have CH &gt; TH, with strand bias. The existence of TL &gt; CL is not clear. Finally, mtDNA of H. sapiens, P. troglodytes (Chimpanzee), and G. domesticus (Chicken) shows clear CH &gt; TH and TL &gt; CL as mentioned in the main manuscript. Interestingly, TL &gt; CL seems to be slightly stronger in the mitochondria of chicken than that of human (or chimp). We suggest there would be some differences in the mechanism of mtDNA replication across the evolution tree.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.015</doi>
							<resource>https://elifesciences.org/articles/02935/figures#fig4s1</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 4—figure supplement 2. Correlation of triplet codon frequencies between from observed and from simulated evolutions under the mtDNA somatic mutational signature.</title>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.016</doi>
							<resource>https://elifesciences.org/articles/02935/figures#fig4s2</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 5. Selection and mutational process for mtDNA somatic substitutions.</title>
							<subtitle>(A) Truncating mutations (nonsense substitutions and frame-shifting (FS) coding indels) present significantly lower VAF. (B) Change of VAF of mtDNA somatic mutation between primary and metastatic (or late) cancer tissues. (C) Mutational signature for mtDNA across various tumor types. None of the three highlighted mechanisms or nuclear DNA double-strand breaks repair mechanism (BRCA) match with the mtDNA mutational signature. * Only substitutions in protein-coding genes considered. (D) A proposed model of mtDNA mutational process.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.017</doi>
							<resource>https://elifesciences.org/articles/02935#fig5</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 5—figure supplement 1. Number of recurrent substitutions between silent and missense substitutions.</title>
							<subtitle>100 sites were randomly selected from silent substitutions (at third base of triplet codon) and missense substitutions (at first and second base of triplet codon). No significant difference was observed among these three groups.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.018</doi>
							<resource>https://elifesciences.org/articles/02935/figures#fig5s1</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 5—figure supplement 2. Comparison of VAF of protein-truncating mutations (nonsense substitution and indels) across tumor types.</title>
							<subtitle>Four tumor types with more than 10 protein-truncating mutations are shown. Fisher's exact were applied between breast and other tissue types.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.019</doi>
							<resource>https://elifesciences.org/articles/02935/figures#fig5s2</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 5—figure supplement 3. Negligible impacts of external mutagens (UV and tobacco smoking) to the somatic mtDNA mutations.</title>
							<subtitle>No evidence of UV and tobacco smoking was identified even in melanoma and lung cancers, respectively. (Left) We compared the proportion of C &gt; T (and G &gt; A) substitutions in the CpC (GpG) context (mutational signature for UV [Alexandrov et al., 2013]) between melanomas and breast cancers (controls). Because UV shows trivial impact to the nuclear DNA somatic mutations of breast cancers (Alexandrov et al., 2013), the vast majority of mtDNA C &gt; T substitutions in the CpC context from breast cancers were not generated by UV. (Right) We compared the proportion of C &gt; A (G &gt; T) substitutions between lung and breast (control) cancers. C &gt; A (G &gt; T) substitutions are dominantly generated by tobacco smoking. Like UV, the impact of tobacco smoking to the somatic mutations of breast cancers is trivial (Alexandrov et al., 2013).</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.02935.020</doi>
							<resource>https://elifesciences.org/articles/02935/figures#fig5s3</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Supplementary file 1.</title>
							<subtitle>Sequencing information of 1675 tumor–normal pairs.</subtitle>
						</titles>
						<format mime_type="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
						<doi_data>
							<doi>10.7554/eLife.02935.021</doi>
							<resource>https://elifesciences.org/articles/02935/figures#SD1-data</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Supplementary file 2.</title>
							<subtitle>Catalogs of somatic mutations (substitutions and indels) and inherited polymorphisms identified in this study.</subtitle>
						</titles>
						<format mime_type="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
						<doi_data>
							<doi>10.7554/eLife.02935.022</doi>
							<resource>https://elifesciences.org/articles/02935/figures#SD2-data</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Supplementary file 3.</title>
							<subtitle>List of phased somatic substitutions.</subtitle>
						</titles>
						<format mime_type="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
						<doi_data>
							<doi>10.7554/eLife.02935.023</doi>
							<resource>https://elifesciences.org/articles/02935/figures#SD3-data</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Supplementary file 4.</title>
							<subtitle>dN/dS for 13 protein-coding genes in mitochondria.</subtitle>
						</titles>
						<format mime_type="application/vnd.ms-excel"/>
						<doi_data>
							<doi>10.7554/eLife.02935.024</doi>
							<resource>https://elifesciences.org/articles/02935/figures#SD4-data</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Supplementary file 5.</title>
							<subtitle>List of somatic substitution with higher recurrent rate than expected.</subtitle>
						</titles>
						<format mime_type="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
						<doi_data>
							<doi>10.7554/eLife.02935.025</doi>
							<resource>https://elifesciences.org/articles/02935/figures#SD5-data</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Supplementary file 6.</title>
							<subtitle>Data accession numbers.</subtitle>
						</titles>
						<format mime_type="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
						<doi_data>
							<doi>10.7554/eLife.02935.026</doi>
							<resource>https://elifesciences.org/articles/02935/figures#SD6-data</resource>
						</doi_data>
					</component>
				</component_list>
			</journal_article>
		</journal>
	</body>
</doi_batch>
